Researchers Develop Assay for Predicting Lung Cancer Drug Response | GenomeWeb

NEW YORK (GenomeWeb News) – In a paper appearing online today in the journal BMC Cancer, a British-led team of scientists showed that looking at the expression of a set of known or suspected drug response genes may offer clues for choosing the most promising non-small cell lung cancer treatments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.